Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Gynecol Obstet ; 284(3): 663-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21046135

ABSTRACT

PURPOSE: To evaluate how many patients with overactive bladder still take their prescribed medication at least 12 months later and to find out the reasons for discontinuation of the therapy. METHODS: Two hundred and ten patients who had received a prescription for anticholinergic medication were contacted by telephone 12-46 months later. RESULTS: Out of 210 eligible patients 132 (63%) could be contacted and gave consent to participate in the study. 38% of them still took their medication after at least 12 months. 17% were continent or much improved, 13% a little improved, 8% were not improved, although still taking their medication. 62% did not take the original medication any more. 10% had never started with the medication, 42% took the medication for 3 months and 8% for 4-12 months. 25% had changed to another anticholinergic drug. CONCLUSION: Anticholinergic therapy is often discontinued by patients and doctors. Patients with OAB therefore need counselling and follow-up in the long term to make sure that alternative treatment is offered if anticholinergic treatment does not work.


Subject(s)
Cholinergic Antagonists/therapeutic use , Medication Adherence/statistics & numerical data , Urinary Bladder, Overactive/drug therapy , Adult , Aged , Aged, 80 and over , Cholinergic Antagonists/adverse effects , Female , Follow-Up Studies , Humans , Interviews as Topic , Middle Aged , Muscarinic Antagonists/adverse effects , Muscarinic Antagonists/therapeutic use , Parasympatholytics/adverse effects , Parasympatholytics/therapeutic use , Treatment Failure , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...